ALEMBIC PHARMACEUTICALS
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Alembic Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.44₹ 4.1
As on Oct 24, 2025, 4:01 PM IST
Alembic Pharmaceuticals Price Performance
Today's LowToday's High
₹910.00₹932.70
₹926.30
52 Weeks' Low52 Weeks' High
₹725.60₹1,152.60
₹926.30
Open Price
₹912.00
Prev. Close
₹922.20
Volume
3,126
Over the last 5 years, the share price of Alembic Pharmaceuticals has declined 0.68% CAGR. Over the past year, the corresponding return has been -13.17%.
Alembic Pharmaceuticals’s current P/E of 30.19x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Alembic Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Alembic Pharmaceuticals | -1.19 | 0.58 | -7.21 | 5.81 | -13.31 | 19.07 | -0.68 |
| Sun Pharmaceutical Industries | 1.22 | 4.40 | 0.06 | -4.88 | -8.64 | 19.88 | 29.07 |
| Divi's Laboratories | 0 | 12.20 | 0 | 10.14 | 14.57 | 22.37 | 16.83 |
| Cipla | 0.38 | 4.90 | 3.44 | 3.82 | 6.38 | 11.37 | 16.28 |
| Torrent Pharmaceuticals | -0.05 | 1.26 | -0.71 | 10.54 | 4.05 | 31.62 | 21.93 |
| Dr. Reddy's Laboratories | 2.31 | 0.80 | 0.58 | 9.50 | -1.37 | 13.65 | 5.23 |
| Zydus Lifesciences | 1.86 | -1.30 | 2.96 | 17.06 | 1.56 | 34.52 | 19.18 |
| Mankind Pharma | -2.22 | -3.84 | -6.84 | -5.03 | -1.37 | 19.39 | 11.22 |
| Lupin | -0.25 | -1.40 | -0.87 | -4.18 | -10.23 | 41.67 | 14.96 |
| Alkem Laboratories | -0.72 | 0.69 | 10.42 | 10.04 | -6.74 | 21.39 | 16.37 |
| Abbott India | 0.31 | -1.04 | -11.46 | 0.51 | 4.82 | 17.65 | 13.94 |
| Aurobindo Pharma | -1.48 | -1.07 | -3.31 | -10.90 | -23.96 | 27.44 | 6.70 |
| Glenmark Pharmaceuticals | -2.30 | -10.47 | -15.20 | 33.82 | 9.30 | 65.89 | 30.65 |
| Laurus Labs | 2.83 | 3.28 | 10.41 | 47.95 | 98.57 | 24.47 | 23.97 |
| Biocon | 0.87 | 0.93 | -8.85 | 15.11 | 14.91 | 9.95 | -2.25 |
| GlaxoSmithKline Pharmaceuticals | 0.43 | 0.75 | -12.73 | -1.81 | 6.44 | 26.09 | 13.05 |
| Anthem Biosciences | -4.95 | -10.48 | -4.83 | -1.44 | -1.44 | -0.48 | -0.29 |
| Cohance Lifesciences | -1.46 | -2.50 | -13.79 | -23.19 | -29.66 | 28.80 | 21.50 |
| Ipca Laboratories | -1.33 | -5.99 | -16.05 | -10.48 | -19.80 | 12.12 | 3.59 |
| Gland Pharma | 0.48 | -1.37 | -3.47 | 34.01 | 21.10 | -3.87 | 1.33 |
Over the last one year, Alembic Pharmaceuticals has declined 13.31% compared to peers like Sun Pharmaceutical Industries (-8.64%), Divi's Laboratories (14.57%), Cipla (6.38%). From a 5 year perspective, Alembic Pharmaceuticals has underperformed peers relative to Sun Pharmaceutical Industries (29.07%) and Divi's Laboratories (16.83%).
Alembic Pharmaceuticals Financials
Alembic Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 930.52 | 928.37 |
| 10 | 932.58 | 928.44 |
| 20 | 922.3 | 929.81 |
| 50 | 942.32 | 940.74 |
| 100 | 965.69 | 948.31 |
| 200 | 934.26 | 955.61 |
Alembic Pharmaceuticals Share Holding Pattern
In the latest quarter, Alembic Pharmaceuticals saw a rise in promoter holding to 69.75%, while DII stake decreased to 16.30%, FII holding rose to 4.04%, and public shareholding moved up to 9.92% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Alembic Pharmaceuticals Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 34,27,766 | 1.77 | 308.96 | |
| 25,50,934 | 1.2 | 229.93 | |
| 15,00,000 | 0.82 | 135.2 | |
| 14,55,416 | 0.51 | 131.18 | |
| 14,34,898 | 0.77 | 129.33 | |
| 11,77,665 | 1.7 | 106.15 | |
| 8,10,789 | 0.63 | 73.08 | |
| 6,08,603 | 0.83 | 54.86 | |
| 4,70,000 | 0.5 | 42.36 | |
| 1,50,000 | 0.98 | 13.52 |
* Excluding Index & Arbitrage Funds
Alembic Pharmaceuticals Futures
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Alembic Pharmaceuticals Options
Alembic Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 23, 2025, 6:00 AM IST | Alembic Pharmaceutic - Board Meeting Intimation for Considering Unaudited Financial Results For The Quarter And Half Year End |
| Oct 18, 2025, 11:32 PM IST | Alembic Pharmaceutic - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Oct 06, 2025, 11:38 PM IST | Alembic Pharmaceutic - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 01, 2025, 3:26 PM IST | Alembic Pharmaceutic - Intimation For Change Of Email Address Of The Registrar And Share Transfer Agent ('RTA') Of The Compan |
| Sep 25, 2025, 6:07 AM IST | Alembic Pharmaceutic - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
About Alembic Pharmaceuticals
Alembic Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 16/06/2010 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ2010PLC061123 and registration number is 061123. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 6032.63 Cr. and Equity Capital is Rs. 39.31 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressAlembic Road, Vadodra Gujarat 390003
- Contact
Management
- Mr. Chirayu AminChairman & CEO
- Mr. Pranav AminManaging Director
- Mr. Shaunak AminManaging Director
- Mr. R K BahetiDirector - Finance & CFO
- Mr. Jai DiwanjiIndependent Director
- Mr. Ashok BaratIndependent Director
- Ms. Geeta GoradiaIndependent Director
- Mr. Manish KejriwalIndependent Director
FAQs on Alembic Pharmaceuticals Share Price
What is the share price of Alembic Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Alembic Pharmaceuticals is ₹926.30 as on Oct 24, 2025.
What kind of stock is Alembic Pharmaceuticals?
The Alembic Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Alembic Pharmaceuticals?
The market cap of Alembic Pharmaceuticals is ₹18,207.64 Cr as on Oct 24, 2025.
What are today's High and Low prices of Alembic Pharmaceuticals?
Today’s highest and lowest price of Alembic Pharmaceuticals are ₹932.70 and ₹910.00.
What are the 52 Week High and 52 Week Low of Alembic Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Alembic Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Alembic Pharmaceuticals is ₹1,152.60 and 52-week low of Alembic Pharmaceuticals is ₹725.60 as on Oct 24, 2025.
How has the Alembic Pharmaceuticals performed historically in terms of returns?
The Alembic Pharmaceuticals has shown returns of 0.44% over the past day, 0.73% for the past month, -9.03% over 3 months, -13.17% over 1 year, 19.07% across 3 years, and -0.68% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Alembic Pharmaceuticals?
P/E ratio of and PB ratio of Alembic Pharmaceuticals are 30.19 and 3.72 on Oct 24, 2025. While the company gives a dividend yield of 1.19 per annum.
Alembic Pharmaceuticals News
✕
Market Pulse